We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.33B
AUM Growth
+$1.69B
Cap. Flow
+$1.15B
Cap. Flow %
15.72%
Top 10 Hldgs %
11.92%
Holding
611
New
202
Increased
183
Reduced
174
Closed
49

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$106M
2
SPXC icon
SPX Corp
SPXC
+$28.8M
3
EQC
Equity Commonwealth
EQC
+$25.2M
4
GIL icon
Gildan
GIL
+$24.7M
5
ICUI icon
ICU Medical
ICUI
+$17.3M

Sector Composition

Rank Sector Weight
1 Industrials 19.48%
2 Technology 18.29%
3 Financials 14.4%
4 Healthcare 13.59%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPO icon
101
Enpro
NPO
$6.63B
$22.8M 0.31%
140,657
+5,051
+4% +$786K
UCB
102
United Community Banks
UCB
$4.24B
$22.6M 0.31%
776,808
+11,322
+1% +$325K
ONTO icon
103
Onto Innovation
ONTO
$12.9B
$22.6M 0.31%
108,676
-25,522
-19% -$5.15M
SYK icon
104
Stryker
SYK
$125B
$22.2M 0.3%
+61,320
New +$21.2M
TXNM
105
TXNM Energy Inc
TXNM
$6.41B
$22M 0.3%
503,283
-55,397
-10% -$2.25M
MP icon
106
MP Materials
MP
$7.36B
$22M 0.3%
1,245,796
+306,933
+33% +$4.17M
PLD icon
107
Prologis
PLD
$135B
$21.5M 0.29%
+170,351
New +$21.1M
SPGI icon
108
S&P Global
SPGI
$121B
$21.3M 0.29%
+41,213
New +$20.4M
QTWO icon
109
Q2 Holdings
QTWO
$3.8B
$21.2M 0.29%
266,079
+9,976
+4% +$704K
MA icon
110
Mastercard
MA
$506B
$20.3M 0.28%
+41,208
New +$19.2M
HALO icon
111
Halozyme
HALO
$9.79B
$20.3M 0.28%
355,176
+49,856
+16% +$2.86M
LKFT
112
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$20.3M 0.28%
705,648
-93,431
-12% -$2.54M
GIL icon
113
Gildan
GIL
$10.3B
$20.3M 0.28%
430,886
-583,409
-58% -$24.7M
IBP icon
114
Installed Building Products
IBP
$6.01B
$20M 0.27%
81,075
+48,559
+149% +$11M
NJR icon
115
New Jersey Resources
NJR
$5.84B
$19.9M 0.27%
422,000
+17,664
+4% +$807K
CARR icon
116
Carrier Global
CARR
$51B
$19.9M 0.27%
+247,231
New +$17.2M
ALE
117
DELISTED
Allete
ALE
$19.8M 0.27%
308,168
-56,647
-16% -$3.61M
PVH icon
118
PVH
PVH
$4B
$19.6M 0.27%
194,695
-42,265
-18% -$4.2M
QDEL icon
119
QuidelOrtho
QDEL
$1.14B
$19.6M 0.27%
+429,057
New +$17.4M
BAM icon
120
Brookfield Asset Management
BAM
$77.3B
$19.1M 0.26%
+403,371
New +$16.9M
HLNE icon
121
Hamilton Lane
HLNE
$4.91B
$18.7M 0.25%
111,029
-31,269
-22% -$4.53M
AIR icon
122
AAR Corp
AIR
$5.59B
$18.6M 0.25%
284,396
-98,191
-26% -$6.5M
WSBC icon
123
WesBanco
WSBC
$3.97B
$18.6M 0.25%
623,541
-11,434
-2% -$351K
GERN icon
124
Geron
GERN
$828M
$18.5M 0.25%
4,077,079
-40,257
-1% -$183K
CVX icon
125
Chevron
CVX
$392B
$18.5M 0.25%
125,646
+60,750
+94% +$9.04M

Similar funds

Segall Bryant & Hamill's Q3 2024 Portfolio in Review

As of Q3 2024, Segall Bryant & Hamill held 611 positions worth $7.33B, up 30% from $5.64B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill deployed $1.15B of net new capital in Q3 2024, opening 202 new positions and adding to 183 existing holdings. Its largest new stake was NVIDIA: 687,551 shares worth $83.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPX Corp, an estimated $28.8M trimmed.

  • Segall Bryant & Hamill's largest Q3 2024 buy was NVIDIA: 687,551 shares worth $83.5M.
  • Segall Bryant & Hamill added most to Microsoft in Q3 2024, an estimated $91.1M increase.
  • Segall Bryant & Hamill's biggest Q3 2024 reduction was SPX Corp, cutting an estimated $28.8M.
  • Segall Bryant & Hamill fully exited Dynatrace in Q3 2024, selling an estimated $106M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.33B portfolio in Q3 2024.
  • Segall Bryant & Hamill opened 202 new positions and closed 49 in Q3 2024.
  • Segall Bryant & Hamill's portfolio value rose 30% quarter-over-quarter to $7.33B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.